Factors influencing lymph node yield in head and neck squamous cell carcinoma: A scoping review

• Published in: Oral oncology 2024-12, Vol.159, p.107070, Article 107070
• Main Authors: Aweeda, Marina, Richard, Kelsey, Arnaud, Ethan H., Divi, Vasu, Goyal, Neerav, Topf, Michael C.
• Format: Article
• Language: English
• Subjects: Disease free survival; Female; Head and neck cancer; Head and Neck Neoplasms - mortality; Head and Neck Neoplasms - pathology; Head and Neck Neoplasms - surgery; Humans; Lymph node yield; Lymph Nodes - pathology; Lymphatic Metastasis; Male; Neck dissection; Oral cancer; Overall survival; Prognosis; Squamous Cell Carcinoma of Head and Neck - mortality; Squamous Cell Carcinoma of Head and Neck - pathology; Squamous Cell Carcinoma of Head and Neck - surgery
• ISSN: 1368-8375; 1879-0593; 1879-0593
• DOI: 10.1016/j.oraloncology.2024.107070

•LNY in HNSCC is influenced by surgeon, pathologist, patient, and subsite characteristics.•Surgeon experience and variation in pathology protocols and personnel can impact LNY.•Extent of nodal dissection and advanced tumor characteristics are associated with increased LNY.•Age >40, male gender, and body mass index (BMI) > 30 are associated with increased LNY.•In the oral cavity and all subsites, LNY > 18 is an independent predictor of improved survival. In head and neck cancer surgery, several studies have demonstrated the prognostic significance of lymph node yield (LNY). To our knowledge, no review has evaluated both the contributing factors to LNY and its impact on survival outcomes across all head and neck squamous cell carcinoma (HNSCC) subsites. A scoping review of LNY in HNSCC was conducted according to The Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) framework to answer the following research questions: 1) Which surgeon, pathologist, and patient characteristics influence LNY? 2) Which anatomic subsites does LNY impact survival? Surgeon experience and variation in pathology protocols and personnel can impact LNY. Extent of nodal dissection, advanced tumor characteristics, and treatment at an academic facility are associated with increased LNY. Patient characteristics such as age  30 are associated with increased LNY. In the oral cavity, LNY > 18 is an independent predictor of improved overall survival (OS), disease free survival (DFS), and disease-specific survival (DSS). In the oropharynx, published studies show mixed results with regards to the impact of LNY on OS, DFS, and DSS. LNY has not been associated with OS or DFS in the larynx, irrespective of nodal threshold. Provider and patient characteristics may impact LNY. LNY ≥ 18 is associated with a survival benefit in the oral cavity and HNSCC overall. Further investigation of LNY particularly in prospective clinical trials is required prior to its adoption as a quality metric in HNSCC.